Quantcast

Cancer/Tumor Profiling Market to Record 18.5 Percent CAGR Through 2018, According to MarketsandMarkets Report Recently Published at MarketPublishers.com

October 8, 2013

In-demand research report “Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018” prepared by MarketsandMarkets has been recently published by Market Publishers Ltd.

London, UK (PRWEB) October 08, 2013

In 2012, the world cancer/tumor profiling market surpassed a USD 13.25 billion mark. At the end of 2013, it is likely to value almost USD 15 billion. North America is the dominant regional market, followed by Europe. Both regional markets are poised to register stable growth in the offing, while the APAC market is forecast to witness robust growth due to the increasing cancer incidence and growing consumers’ purchasing power.

The worldwide cancer/tumor profiling market is forecast to record an 18.5 percent CAGR in the years to come and to override USD 35 billion by 2018. The key factors driving the market growth include ongoing technological advancements in the cancer/tumor profiling industry, investments growth and increasing demand for cost-effective and safe drugs for cancer treatment.

In-demand research report “Cancer/Tumor Profiling Market (Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics) 2013 – 2018” prepared by MarketsandMarkets has been recently published by Market Publishers Ltd.

Report Details:

Title: Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018

Published: September, 2013

Pages: 173

Price:    US$ 4,650.00

http://marketpublishers.com/report/diagnostics-diseases/cancer/cancertumor-profiling-market-applications-personalized-medicine-diagnostics-biomarker-discovery-prognosis-research-technologies-ngs-qpcr-ihc.html

The report provides a comprehensive analysis of the global cancer/tumor profiling market. It uncovers qualitative and quantitative information on the industry performance, presents extensive market assessment by geography, applications, technologies and segment types. The research study contains an insightful technological analysis, value chain analysis and Porter’s five forces analysis, evaluates the investment environment, discusses the important industry trends and issues, scrutinizes the key factors driving and restraining the market. The report delves into the competitive environment, reviews leading companies operating in the market, traces recent industry activity and, moreover, outlines prospects for the future development of the global cancer/tumor profiling market.

Report Scope:

  •     In-depth analysis of the global cancer/tumor profiling market.
  •     Comprehensive market assessment by geography, applications, technologies and segment types.
  •     Vital qualitative and quantitative information on the industry performance.
  •     Profound reviews of the major technological trends.
  •     Porter’s five forces analysis.
  •     Value chain analysis.
  •     Evaluation of the investment environment.
  •     Examination of the top factors influencing the market growth.
  •     Description of the competitive scenario.
  •     Review of the top companies.
  •     Data on the most recent industry activity.
  •     Detailed future forecast through 2018.

More insightful research reports by the publisher can be found at MarketsandMarkets page.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11209373.htm


Source: prweb



comments powered by Disqus